UK: UK Authorizes World-First Gene Therapy From Vertex And CRISPR Therapeutics For Blood Disorders - Goodwin Procter LLP

Mondaq

22 Nov 2023 0 shares 1 views

UK: UK Authorizes World-First Gene Therapy From Vertex And CRISPR Therapeutics For Blood Disorders - Goodwin Procter LLP

Mondaq

Published 22 Nov 2023

Earlier today, UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorization to Vertex Pharmaceuticals and CRISPR Therapeutics...

Full Article

United States: FDA To Review Vertex Pharmaceutical's Application For CRISPR-Based Gene Therapy Exa-Cel - Goodwin Procter LLP

The Cellular, Tissue, and Gene Therapies Advisory Committee of the FDA is meeting tomorrow, Tuesday, October 31, 2023, to review a..

Mondaq 01 Nov 2023

UK: UK Authorizes World-First Gene Therapy From Vertex And CRISPR Therapeutics For Blood Disorders - Goodwin Procter LLP

UK: UK Authorizes World-First Gene Therapy From Vertex And CRISPR Therapeutics For Blood Disorders - Goodwin Procter LLP

You might like

Related news coverage

United States: FDA To Review Vertex Pharmaceutical's Application For CRISPR-Based Gene Therapy Exa-Cel - Goodwin Procter LLP

Advertisement